Market Closed -
Bombay S.E.
12:11:48 2024-05-18 am EDT
|
5-day change
|
1st Jan Change
|
1,323
INR
|
+0.00%
|
|
+2.58%
|
+25.59%
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
18,694
|
15,396
|
32,134
|
33,392
|
27,855
|
60,316
|
-
|
-
|
Enterprise Value (EV)
1 |
17,943
|
14,616
|
30,326
|
31,417
|
26,893
|
46,595
|
57,343
|
55,017
|
P/E ratio
|
17.1
x
|
10.9
x
|
15.5
x
|
16
x
|
12.1
x
|
19.5
x
|
21.6
x
|
18.5
x
|
Yield
|
0.15%
|
3.71%
|
0.29%
|
1.95%
|
0.33%
|
0.77%
|
0.68%
|
0.63%
|
Capitalization / Revenue
|
1.86
x
|
1.37
x
|
2.32
x
|
2.26
x
|
1.64
x
|
2.65
x
|
2.97
x
|
2.62
x
|
EV / Revenue
|
1.78
x
|
1.3
x
|
2.19
x
|
2.13
x
|
1.58
x
|
2.65
x
|
2.82
x
|
2.39
x
|
EV / EBITDA
|
12.3
x
|
8.43
x
|
11.3
x
|
11.9
x
|
9.65
x
|
14.2
x
|
15.5
x
|
12.9
x
|
EV / FCF
|
-1,042
x
|
9.85
x
|
13.9
x
|
70.7
x
|
223
x
|
35.1
x
|
31.7
x
|
25.7
x
|
FCF Yield
|
-0.1%
|
10.2%
|
7.2%
|
1.41%
|
0.45%
|
2.85%
|
3.15%
|
3.9%
|
Price to Book
|
2.91
x
|
2.18
x
|
4.09
x
|
3.48
x
|
2.62
x
|
4.83
x
|
4.15
x
|
3.55
x
|
Nbr of stocks (in thousands)
|
47,578
|
47,578
|
46,578
|
46,578
|
45,578
|
45,578
|
-
|
-
|
Reference price
2 |
392.9
|
323.6
|
689.9
|
716.9
|
611.2
|
1,323
|
1,323
|
1,323
|
Announcement Date
|
5/21/19
|
6/10/20
|
5/21/21
|
5/23/22
|
5/25/23
|
5/17/24
|
-
|
-
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
10,058
|
11,201
|
13,875
|
14,778
|
17,002
|
17,585
|
20,313
|
23,002
|
EBITDA
1 |
1,460
|
1,735
|
2,691
|
2,634
|
2,787
|
3,274
|
3,694
|
4,262
|
EBIT
1 |
1,336
|
1,571
|
2,539
|
2,471
|
2,611
|
2,869
|
3,357
|
3,862
|
Operating Margin
|
13.29%
|
14.03%
|
18.3%
|
16.72%
|
15.36%
|
16.31%
|
16.53%
|
16.79%
|
Earnings before Tax (EBT)
1 |
1,540
|
1,806
|
2,849
|
2,775
|
3,027
|
3,188
|
3,579
|
4,145
|
Net income
1 |
1,126
|
1,415
|
2,106
|
2,088
|
2,335
|
2,391
|
2,723
|
3,152
|
Net margin
|
11.19%
|
12.63%
|
15.18%
|
14.13%
|
13.73%
|
13.6%
|
13.41%
|
13.7%
|
EPS
2 |
23.02
|
29.73
|
44.61
|
44.82
|
50.35
|
52.46
|
61.13
|
71.52
|
Free Cash Flow
1 |
-17.21
|
1,484
|
2,184
|
444.5
|
120.5
|
1,686
|
1,808
|
2,144
|
FCF margin
|
-0.17%
|
13.25%
|
15.74%
|
3.01%
|
0.71%
|
9.4%
|
8.9%
|
9.32%
|
FCF Conversion (EBITDA)
|
-
|
85.54%
|
81.17%
|
16.88%
|
4.32%
|
52%
|
48.94%
|
50.31%
|
FCF Conversion (Net income)
|
-
|
104.89%
|
103.75%
|
21.29%
|
5.16%
|
70.78%
|
66.4%
|
68.04%
|
Dividend per Share
2 |
0.6000
|
12.00
|
2.000
|
14.00
|
2.000
|
10.20
|
8.975
|
8.329
|
Announcement Date
|
5/21/19
|
6/10/20
|
5/21/21
|
5/23/22
|
5/25/23
|
5/17/24
|
-
|
-
|
Fiscal Period: March |
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
8,162
|
2,957
|
2,756
|
3,638
|
4,388
|
3,569
|
3,183
|
3,927
|
5,429
|
3,634
|
3,712
|
3,691
|
5,972
|
4,258
|
3,905
|
EBITDA
1 |
1,543
|
502.2
|
646.2
|
611.1
|
821.6
|
550.3
|
650.8
|
514.8
|
975.2
|
518.3
|
778.7
|
436.1
|
1,081
|
654.7
|
700.2
|
EBIT
|
-
|
460.9
|
599.5
|
573
|
781
|
510.7
|
606.3
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
15.59%
|
21.75%
|
15.75%
|
17.8%
|
14.31%
|
19.05%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
544.6
|
675.6
|
641.6
|
843.4
|
569.2
|
720.6
|
637.5
|
979.7
|
542.6
|
867.5
|
447.3
|
1,099
|
587
|
752.5
|
Net income
1 |
-
|
400.4
|
486.4
|
486
|
633.8
|
425.2
|
542.9
|
491.1
|
730.2
|
460.7
|
653.1
|
329.4
|
800
|
468.5
|
545.8
|
Net margin
|
-
|
13.54%
|
17.65%
|
13.36%
|
14.44%
|
11.91%
|
17.06%
|
12.51%
|
13.45%
|
12.68%
|
17.59%
|
8.92%
|
13.4%
|
11%
|
13.98%
|
EPS
|
-
|
8.540
|
10.45
|
10.43
|
13.61
|
9.130
|
11.65
|
-
|
-
|
-
|
-
|
-
|
16.90
|
-
|
11.15
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/30/20
|
2/2/21
|
5/21/21
|
7/29/21
|
10/30/21
|
2/2/22
|
5/23/22
|
8/2/22
|
11/1/22
|
2/10/23
|
5/25/23
|
8/2/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
750
|
780
|
1,808
|
1,975
|
962
|
1,070
|
2,973
|
5,299
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-17.2
|
1,484
|
2,184
|
445
|
121
|
1,686
|
1,808
|
2,144
|
ROE (net income / shareholders' equity)
|
17.7%
|
21%
|
28%
|
23.8%
|
23.1%
|
20.5%
|
20.3%
|
20.3%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
15.8%
|
15.7%
|
15.4%
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
15,076
|
17,344
|
20,465
|
Book Value Per Share
2 |
135.0
|
149.0
|
169.0
|
206.0
|
233.0
|
274.0
|
319.0
|
373.0
|
Cash Flow per Share
2 |
31.80
|
34.10
|
49.00
|
22.40
|
29.90
|
48.90
|
54.90
|
65.00
|
Capex
1 |
60.8
|
137
|
126
|
598
|
1,242
|
1,489
|
590
|
772
|
Capex / Sales
|
0.6%
|
1.22%
|
0.91%
|
4.05%
|
7.3%
|
8.3%
|
2.9%
|
3.35%
|
Announcement Date
|
5/21/19
|
6/10/20
|
5/21/21
|
5/23/22
|
5/25/23
|
5/17/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +25.59% | 732M | | +2.08% | 3.61B | | -19.91% | 2.15B | | -7.20% | 1.95B | | +2.34% | 1.9B | | +1.54% | 1.71B | | -3.83% | 1.3B | | +3.39% | 1.19B | | -18.55% | 1.06B | | +2.18% | 1.06B |
Pesticide
|